|
C1ORF58 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.192000E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.034050E-02 |
| Normal-vs-Stage2 |
5.602800E-01 |
| Normal-vs-Stage3 |
6.852200E-01 |
| Normal-vs-Stage4 |
5.431200E-01 |
| Stage1-vs-Stage2 |
4.126000E-01 |
| Stage1-vs-Stage3 |
2.332600E-01 |
| Stage1-vs-Stage4 |
6.756400E-01 |
| Stage2-vs-Stage3 |
8.573200E-01 |
| Stage2-vs-Stage4 |
8.729600E-01 |
| Stage3-vs-Stage4 |
7.578200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.092400E-02 |
| Normal-vs-AfricanAmerican |
2.803900E-02 |
| Normal-vs-Asian |
1.596450E-02 |
| Caucasian-vs-AfricanAmerican |
5.499200E-01 |
| Caucasian-vs-Asian |
3.966400E-01 |
| AfricanAmerican-vs-Asian |
4.457800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.603900E-03 |
| Normal-vs-Female |
4.788400E-01 |
| Male-vs-Female |
1.921010E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.909600E-02 |
| Normal-vs-Extreme_Weight |
2.780500E-04 |
| Normal-vs-Obese |
3.494400E-01 |
| Normal-vs-Extreme_Obese |
2.298400E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.435000E-01 |
| Normal_Weight-vs-Obese |
3.968000E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.711800E-01 |
| Extreme_Weight-vs-Obese |
1.529820E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.054400E-01 |
| Obese-vs-Extreme_Obese |
4.770000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.220400E-01 |
| Normal-vs-Age(41-60Yrs) |
3.085800E-01 |
| Normal-vs-Age(61-80Yrs) |
5.977300E-03 |
| Normal-vs-Age(81-100Yrs) |
3.135200E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.743200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.109600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.005600E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.410100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.198240E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.831400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.977930E-03 |
| Normal-VS-Type2 PRCC |
2.422000E-01 |
| Normal-VS-KIRP CIMP |
2.009000E-01 |
| Normal-VS-Unclassified PRCC |
5.514000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.465020E-01 |
| Type1 PRCC-VS-KIRP CIMP |
5.340700E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
2.462400E-02 |
| Type2 PRCC-VS-KIRP CIMP |
6.633700E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.648190E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.521400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.477210E-03 |
| Normal-vs-N1 |
5.080400E-01 |
| Normal-vs-N2 |
3.357200E-01 |
| N0-vs-N1 |
2.251700E-02 |
| N0-vs-N2 |
6.643800E-01 |
| N1-vs-N2 |
4.687000E-01 |
|
|
